app

Meeting Coverage

BCS

Breast Cancer Symposium

Drug Works in AI-Resistant Breast Cancer

SAN FRANCISCO -- A tamoxifen-like drug slowed progression of advanced breast cancer previously treated with a nonsteroidal aromatase inhibitor, results of a small Japanese trial suggested.

image

Latest BCS Meeting Coverage

Afinitor Helps Breast Tx in Older Patients

SAN FRANCISCO -- Older patients with advanced breast cancer had significant improvement in progression-free survival when everolimus was added to exemestane, a new analysis of a randomized trial showed.

September 18, 2012
Young Women Skip Mammo After USPSTF Recs

SAN FRANCISCO -- Rates of screening mammography among women younger than 50 declined within 2 months of a negative recommendation by the U.S. Preventive Services Task Force (USPSTF) and have remained below baseline rates, according to a study reported here.

September 15, 2012
Device May Cut Re-Excision Rate in Breast Cancer

SAN FRANCISCO -- Re-excision after breast-conserving surgery occurred 50% less often with intraoperative margin assessment by a device that distinguishes cancer cells from normal tissue, results of a randomized study showed.

September 12, 2012
MBCS: Lumpectomy 'Safe' for Young Breast Cancer Patients

SAN FRANCISCO -- Lumpectomy doesn't carry higher recurrence or mortality risk than mastectomy for young women with breast cancer, two separate studies found.

September 7, 2011